Table 3.
Drug-Related Information Among the ART Patients in the ART Clinic of DRH from January 10/2016 to December 11/2018
Variables | Category | IPT Group No. (%) | Non-IPT Group No. (%) | P-value |
---|---|---|---|---|
ART regimen | (TDF/3TC/EFV) | 98(89.09%) | 89(80.90%) | 0.114 |
(TDF/3TC/NVP) | 1(0.90%) | 7(6.36%) | ||
(AZT/3TC/EFV) | 0(0) | 1(0.90%) | ||
(AZT/3TC/NVP) | 5(4.54%) | 10(9.90%) | ||
(ABC/3TC/EFV) | 1(0.90%) | 1(0.90%) | ||
(ABC/3TC/NVP) | 5(4.54%) | 2(1.81%) | ||
CPT | 78(72.2%) | 79(69.9%) | 0.376 | |
Fluconazole | 4(3.7%) | 3(2.65%) | 0.568 | |
Grisseofulvin | 1(0.9%) | 1(0.9%) | ||
Ketoconazole | 0(0) | 1(0.9%) | ||
Diclofenac | 8(7.4%) | 12(10.6%) | 0.617 | |
Ibuprofen | 2(1.8%) | 1(0.9%) | ||
Paracetamol | 9(8.3%) | 12(8.8%) | ||
Albendazole | 5(4.6%) | 4(3.5%) | 0.191 | |
Praziquantel | 1(0.9%) | 0(0) |